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Abstract 
The aim of this thesis was to compare minimally invasive- with traditional open surgical 
techniques for various diseases with regards to cost-effectiveness. Health economic 
evaluations were performed using data from clinical trials and routine care data from 
registers. The healthcare perspective was represented in all four studies and the societal 
perspective (including sick-leave costs) was represented in three out of four studies. 
Paper I included a cost-minimization analysis of laparoscopic and open surgery as 
treatment for rectal cancer within the randomized, controlled COLOR II trial. From the 
healthcare perspective laparoscopic surgery was costlier while from the societal 
perspective no significant long-term difference was observed. Paper II included a cost 
analysis of laparoscopic lavage versus Hartmann’s procedure as treatment for 
complicated diverticulitis with purulent peritonitis within the randomized, controlled 
DILALA trial. Laparoscopic lavage was considered less costly both at 12 months and 
throughout patients’ expected life, from the healthcare perspective. Paper III was a cost 
analysis of robot-assisted laparoscopic prostatectomy (RALP) versus open surgery for 
prostate cancer within the prospective trial LAPPRO. RALP was associated with a 
higher mean cost than open surgery from both the healthcare and societal perspective at 
24 months. Paper IV was a prospective cohort study of cost-effectiveness for 
laparoscopic versus open surgery as treatment for colorectal cancer, with resource use 
data and unit costs derived from Swedish national registers. Laparoscopic surgery was 
associated with better clinical and cost outcomes from both healthcare and societal 
perspectives at 12 months after primary surgery. 
Minimally invasive surgery can be cost saving compared to conventional open surgery. 
It is advisable to perform economic evaluations in routine care, as cost-effectiveness of 
surgical techniques most likely will change over time. 
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